Nuveen Dow 30 Dynamic Overwrite Fund

Nuveen Dow 30 Dynamic Overwrite Fund is a closed-ended equity mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in stocks of large cap companies. The fund also invests through call options. It seeks to replicate the performance of Dow Jones Industrial Average. The fund was formerly known as Dow 30 Premium & Dividend Income Fund Inc. Nuveen Dow 30 Dynamic Overwrite Fund was formed on April 29, 2005 and is domiciled in the United States.

Nuveen Dow 30 Dynamic Overwrite Fund trades as DIAX on NYSE. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $20.49M of revenue and $52.22M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nuveen Dow 30 Dynamic Overwrite Fund can be compared against peers such as Alger Focus Equity Fund, Blackstone/GSO Strategic Credit Fund, BlackRock Debt Strategies Fund, Inc., PGIM Global High Yield Fund, Inc, Guggenheim Active Allocation Fund, Leuthold Core Investment Fund.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $512.77M, beta of 0.73, and return on equity of +8.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

DIAX currently shows total debt of $0 and beta of 0.73. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 25-NSE (2026-03-30 00:00:00), N-CEN (2026-03-16 00:00:00), N-CSR (2026-03-06 00:00:00), NPORT-P (2026-02-26 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=DIAX

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.